We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will UnitedHealth (UNH) Dividend Hike Fail to Excite Investors?
Read MoreHide Full Article
UnitedHealth Group Incorporated (UNH - Free Report) recently announced an increase in its dividend payout, reinforcing its commitment to enhancing stockholder returns. Its board of directors approved an 11.7% hike in the quarterly cash dividend, raising it from $1.88 per share to $2.10.
The latest dividend will be paid out on Jun 25, 2024, to its shareholders of record as of Jun 17. Its dividend yield, based on the latest payout and the Jun 7, 2024 closing price, is 1.71%. The figure is higher than the industry average of 1.39%, the medical sector’s 1.43%, as well as the S&P 500’s level of 1.27%. UnitedHealth’s dividend history shows continuous hikes per annum since 2010.
UNH's robust balance sheet, along with steady cash flow from operations over the years, underpins its initiatives to enhance shareholder value. At the end of the first quarter of 2024, the company's total debt-to-total capital ratio was 40.9%, which is better than the industry's average of 43.9%. UNH projects operating cash flow for 2024 to be between $30 billion and $31 billion, indicating an increase from $29.1 billion in 2023. This growth highlights the strength of its profitable operations.
However, not everything is rosy.
The company is currently facing some challenges, and investors still might be wary. UnitedHealth’s health services division, Optum, was impacted by a cyber-attack on Change Healthcare, a part of this business. The attack significantly affected its operating cash flows in the first quarter.
The cyberattack on Change Healthcare, a platform utilized by hospitals, doctors' offices and pharmacies, has prompted healthcare stakeholders to consider backup options. The long-term impact of this incident on UNH remains uncertain. In response to the cyberattack and the sale of its operations in Brazil, the company has revised its net profit forecast for the full year 2024.
The Zacks Consensus Estimate for 2024 adjusted earnings for UNH is currently pegged at $27.57 per share, which declined by 18 cents in the past 60 days. During this time, its earnings estimate witnessed no upward estimate revisions but nine downward movements. Also, we expect its medical care ratio to deteriorate in 2024 to 84.5% from 83.2% in 2023.
Price Performance
The stock has declined 0.3% in the past year against the industry’s 0.4% growth.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
UnitedHealth currently has a Zacks Rank #4 (Sell).
The Zacks Consensus Estimate for Sera Prognostics’ 2024 bottom line suggests a 19% year-over-year improvement. SERA‘s average earnings surprise for the past four quarters is 3.7%. The consensus mark for its current-year revenues indicates a 14.4% year-over-year increase.
The Zacks Consensus Estimate for HealthEquity’s current-year earnings implies a 30.2% increase from the year-ago reported figure. HQY beat earnings estimates in each of the last four quarters, with an average surprise of 17.2%. The consensus mark for its current-year revenues is pegged at $1.2 billion, which indicates a 15.9% year-over-year increase.
The Zacks Consensus Estimate for Brookdale Senior’s full-year 2024 earnings suggests a 38.1% year-over-year improvement. It has witnessed one upward estimate revision over the past 60 days against no movement in the opposite direction. BKD beat earnings estimates in two of the past four quarters and missed on the other occasions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Will UnitedHealth (UNH) Dividend Hike Fail to Excite Investors?
UnitedHealth Group Incorporated (UNH - Free Report) recently announced an increase in its dividend payout, reinforcing its commitment to enhancing stockholder returns. Its board of directors approved an 11.7% hike in the quarterly cash dividend, raising it from $1.88 per share to $2.10.
The latest dividend will be paid out on Jun 25, 2024, to its shareholders of record as of Jun 17. Its dividend yield, based on the latest payout and the Jun 7, 2024 closing price, is 1.71%. The figure is higher than the industry average of 1.39%, the medical sector’s 1.43%, as well as the S&P 500’s level of 1.27%. UnitedHealth’s dividend history shows continuous hikes per annum since 2010.
UNH's robust balance sheet, along with steady cash flow from operations over the years, underpins its initiatives to enhance shareholder value. At the end of the first quarter of 2024, the company's total debt-to-total capital ratio was 40.9%, which is better than the industry's average of 43.9%. UNH projects operating cash flow for 2024 to be between $30 billion and $31 billion, indicating an increase from $29.1 billion in 2023. This growth highlights the strength of its profitable operations.
However, not everything is rosy.
The company is currently facing some challenges, and investors still might be wary. UnitedHealth’s health services division, Optum, was impacted by a cyber-attack on Change Healthcare, a part of this business. The attack significantly affected its operating cash flows in the first quarter.
The cyberattack on Change Healthcare, a platform utilized by hospitals, doctors' offices and pharmacies, has prompted healthcare stakeholders to consider backup options. The long-term impact of this incident on UNH remains uncertain. In response to the cyberattack and the sale of its operations in Brazil, the company has revised its net profit forecast for the full year 2024.
The Zacks Consensus Estimate for 2024 adjusted earnings for UNH is currently pegged at $27.57 per share, which declined by 18 cents in the past 60 days. During this time, its earnings estimate witnessed no upward estimate revisions but nine downward movements. Also, we expect its medical care ratio to deteriorate in 2024 to 84.5% from 83.2% in 2023.
Price Performance
The stock has declined 0.3% in the past year against the industry’s 0.4% growth.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
UnitedHealth currently has a Zacks Rank #4 (Sell).
Some better-ranked players in the broader Medical space are Sera Prognostics, Inc. (SERA - Free Report) , HealthEquity, Inc. (HQY - Free Report) and Brookdale Senior Living Inc. (BKD - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Sera Prognostics’ 2024 bottom line suggests a 19% year-over-year improvement. SERA‘s average earnings surprise for the past four quarters is 3.7%. The consensus mark for its current-year revenues indicates a 14.4% year-over-year increase.
The Zacks Consensus Estimate for HealthEquity’s current-year earnings implies a 30.2% increase from the year-ago reported figure. HQY beat earnings estimates in each of the last four quarters, with an average surprise of 17.2%. The consensus mark for its current-year revenues is pegged at $1.2 billion, which indicates a 15.9% year-over-year increase.
The Zacks Consensus Estimate for Brookdale Senior’s full-year 2024 earnings suggests a 38.1% year-over-year improvement. It has witnessed one upward estimate revision over the past 60 days against no movement in the opposite direction. BKD beat earnings estimates in two of the past four quarters and missed on the other occasions.